macrosyn- tulathromycin injection, solution
bimeda, inc. - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422) - brd – macrosyn injectable solution is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica , pasteurella multocida , histophilus somni , and mycoplasma bovis ; and for the control of respiratory disease in cattle at high risk of developing brd associated with mannheimia haemolytica , pasteurella multocida , histophilus somni , and mycoplasma bovis . ibk – macrosyn injectable solution is indicated for the treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis . foot rot – macrosyn injectable solution is indicated for the treatment of bovine foot rot (interdigital necrobacillosis) associated with fusobacterium necrophorum and porphyromonas levii . brd – macrosyn injectable solution is indicated for the treatment of brd associated with m. haemolytica , p. multocida , h. somni , and m. bovis . macrosyn injectable solution is indicated for the treatment of swine respiratory disease (srd) associated with actinobacillus pleurop
increxxa- tulathromycin injection
elanco us inc. - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422) - brd – increxxa injectable solution is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni, and mycoplasma bovis ; and for the control of respiratory disease in cattle at high risk of developing brd associated with mannheimia haemolytica , pasteurella multocida , histophilus somni , and mycoplasma bovis . ibk – increxxa injectable solution is indicated for the treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis . foot rot – increxxa injectable solution is indicated for the treatment of bovine foot rot (interdigital necrobacillosis) associated with fusobacterium necrophorum and porphyromonas levii . brd – increxxa injectable solution is indicated for the treatment of brd associated with m. haemolytica , p. multocida , h. somni , and m. bovis . increxxa injectable solution is indicated for the treatment of swine respiratory disease (srd) associated with actinobacillus pleuropne
arovyn- tulathromycin injection
merck sharp & dohme corp - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422) - beef and non-lactating dairy cattle brd – arovyn injectable solution is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni , and mycoplasma bovis ; and for the control of respiratory disease in cattle at high risk of developing brd associated with mannheimia haemolytica, pasteurella multocida, histophilus somni , and mycoplasma bovis . ibk – arovyn injectable solution is indicated for the treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis . foot rot – arovyn injectable solution is indicated for the treatment of bovine foot rot (interdigital necrobacillosis) associated with fusobacterium necrophorum and porphyromonas levii. suckling calves, dairy calves, and veal calves brd - arovyn injectable solution is indicated for the treatment of brd associated with m. haemolytica, p. multocida, h. somni , and m. bovis . swine arovyn injectable solution is indicated for the treatment of
tulissin 100- tulathromycin injection, solution
virbac ah, inc. - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422) - beef and non-lactating dairy cattle brd - tulissin 100 injectable solution is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni, and mycoplasma bovis ; and for the control of respiratory disease in cattle at high risk of developing brd associated with mannheimia haemolytica, pasteurella multocida, histophilus somni, and mycoplasma bovis . ibk - tulissin 100 injectable solution is indicated for the treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis . foot rot - tulissin 100 injectable solution is indicated for the treatment of bovine foot rot (interdigital necrobacillosis) associated with fusobacterium necrophorum and porphyromonas levii . suckling calves, dairy calves, and veal calves brd - tulissin 100 injectable solution is indicated for the treatment of brd associated with m. haemolytica, p. multocida, h. somni, and m. bovis. swine tulissin 100 in
draxxin injectable solution
zoetis australia pty ltd - tulathromycin - parenteral liquid/solution/suspension - tulathromycin antibiotic active 100.0 mg/ml - antibiotic & related - cattle | pig - adult | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | s - bovine respiratory disease | haemophilus spp. | histophilus somni | mannheimia haemolytica | mycoplasma bovis | mycoplasma hyopneumoniae | pasteurella multocida | respiratory disease | fowl cholera | haemophilus agni | haemophilus bovis | haemophilus parainfluenzae | haemophilus parasuis | haemophilus pleuropneumoniae | haemophilus somnus | haemophilus suis | reduction of lung lesions | respiratory disease | shipping fever | swine enzootic pneumonia
tulathromycin
zoetis australia pty ltd - tulathromycin - unknown - tulathromycin antibiotic active 0.0 - active constituent
tulathromycin
abbey laboratories pty ltd - tulathromycin - unknown - tulathromycin antibiotic active 0.0 - active constituent
tulathromycin
zoetis australia pty ltd - tulathromycin - unknown - tulathromycin antibiotic active 0.0 - active constituent
tulathromycin
troy laboratories pty ltd - tulathromycin - unknown - tulathromycin antibiotic active 0.0 - active constituent
tulathromycin
virbac (australia) pty ltd - tulathromycin - unknown - tulathromycin antibiotic active 0.0 - active constituent